EX-99.1 2 bwxt_93022xerexhibit991.htm EX-99.1 Document
erheadera.jpg
BWX Technologies Reports Third Quarter 2022 Results
•3Q22 revenue of $523.7 million
•3Q22 net income of $61.8 million, adjusted EBITDA(1) of $100.1 million
•3Q22 diluted GAAP EPS of $0.67, non-GAAP(1) EPS of $0.69
•3Q22 net cash provided by operating activities of $65.0 million, free cash flow(1) of $25.4 million
•Narrows 2022 guidance and anticipates strong revenue and EBITDA(1) growth in 2023
•Technetium 99-m generator application accepted by FDA with priority review classification
Lynchburg, VA – November 7, 2022 - BWX Technologies, Inc. (NYSE: BWXT) ("BWXT", "we", "us" or the "Company") reported third quarter 2022 GAAP net income attributable to BWXT of $61.6 million, or diluted earnings per share (EPS) of $0.67, on revenue of $523.7 million. Third quarter 2022 non-GAAP(1) net income attributable to BWXT was $63.0 million, or $0.69 diluted EPS. Third quarter 2022 adjusted earnings before interest, taxes, depreciation, and amortization (EBITDA)(1) was $100.1 million. A reconciliation of non-GAAP results are detailed in Exhibit 1.
“BWXT delivered third quarter results that were in line with our expectations that we framed in the second quarter earnings call," said Rex D. Geveden, president and chief executive officer. “Strong performance from Commercial Operations combined with cost control initiatives offset headwinds in the Government Operations segment attributable to lower than projected production volumes due to hiring challenges in a tough macro labor market impacting many industries. We are continuing to address attrition and transitory labor shortages by implementing a set of comprehensive actions including aggressive recruiting, enhanced training and retention measures.”
Geveden continued, “In the past couple of months, BWXT has made exciting progress in two important nuclear growth end-markets: nuclear medicine and commercial nuclear power. In September, we submitted our Tc-99m generator application to the FDA and last week we were notified by the FDA that our application has been accepted with a priority review classification. Also in September, BWXT Medical completed the first trial batch of Actinium-225 for Bayer’s evaluation in therapeutic clinical trials. In August, BWXT's clean-energy business was awarded a contract from GE-Hitachi to begin engineering for its BWRX-300 small modular reactor (SMR) pressure vessel that will enable us to begin manufacturing and procurement preparations. This award firmly supports the global interest in clean-energy SMR technology, and BWXT is well suited to provide design and efficient manufacturing solutions for complex nuclear components to GE-Hitachi as well as other SMR solutions.”
“Given current labor dynamics, we are narrowing 2022 earnings guidance by bringing down the top-end of the range. However, with the company’s new wins, recent growth initiative progress, and positive secular tailwinds in BWXT’s nuclear end-markets, we anticipate strong operational growth in 2023 and accelerating growth over the medium-term,” said Geveden.
(1) A reconciliation of non-GAAP results, including adjusted EBITDA, are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.

Financial Results Summary
Three Months Ended September 30,
20222021$ Change% Change
(Unaudited)
(In millions, except per share amounts)
Revenues
Government Operations$422.5 $417.1 $5.4 1%
Commercial Operations$101.8 $83.4 $18.4 22%
Consolidated$523.7 $498.7 $25.0 5%
Operating Income
Government Operations$77.7 $87.5 $(9.8)(11)%
Commercial Operations$6.8 $4.9 $1.9 39%
Unallocated Corporate (Expense) Income$(4.7)$(5.0)$0.3 NM
Consolidated$79.9 $87.5 $(7.6)(9)%
Consolidated non-GAAP(1)
$81.5 $88.2 $(6.7)(8)%
EPS (Diluted)
GAAP$0.67 $0.63 $0.04 6%
Non-GAAP(1)
$0.69 $0.76 $(0.07)(9)%
Net Income
GAAP$61.8 $60.2 $1.7 3%
Non-GAAP(1)
$63.2 $72.2 $(9.0)(12)%
Adjusted EBITDA(1)
Government Operations$90.4 $98.6 $(8.3)(8)%
Commercial Operations$11.5 $10.2 $1.2 12%
Corporate$(1.7)$(3.1)$1.5 NM
Consolidated$100.1 $105.7 $(5.6)(5)%
Cash Flows
Net Cash Provided By Operating Activities$65.0 $67.3 $(2.3)(3)%
Purchases of Property, Plant and Equipment$39.6 $66.5 $(26.8)(40)%
Free Cash Flow(1)
$25.4 $0.8 $24.6 NM
Repurchases of Common Stock$— $165.8 $(165.8)NM
Dividends Paid to Common Shareholders$20.1 $20.0 $0.2 1%
NM = Not Meaningful

Revenues
Third quarter revenue increased in both operating segments. The Government Operations increase was driven by higher naval production and microreactors volume, partially offset by lower long-lead material production. The Commercial Operations increase was driven by higher field services, higher fuel handling and an increase in medical sales.
Operating Income and Adjusted EBITDA(1)
Third quarter total operating income decreased driven by lower operating income in Government Operations that was partially offset by higher operating income in Commercial Operations. The Government Operations decrease was driven by decreased labor efficiencies that resulted in fewer favorable contract adjustments, lower recoverable CAS pension income, and higher depreciation and acquisition amortization, partially offset by higher income in technical service joint ventures. The Commercial Operations increase was driven by higher revenue, a more favorable business mix and segment cost controls.
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.

Third quarter total adjusted EBITDA(1) decreased for the reasons noted above as lower Government Operations adjusted EBITDA(1) was partially offset by higher Commercial Operations adjusted EBITDA(1).
EPS
The third quarter GAAP EPS increase was driven primarily by the absence of cost associated with an early bond redemption that occurred in the third quarter 2021 and lower share count, partially offset by lower FAS/CAS pension income, higher interest expense and a higher effective tax rate. The third quarter non-GAAP EPS decrease was driven by lower operating and FAS/CAS pension income, higher interest expense, and a higher effective tax rate, which was partially offset by a lower share count.
Cash Flows
Decreased operating cash flow was driven by higher cash taxes, partially offset by more favorable changes in working capital. Lower capital expenditures were driven by less spend on two major growth capital campaigns, for U.S. naval nuclear reactors and medical radioisotopes, that are nearing completion.
Dividend
BWXT paid $20.1 million dollars, or $0.22 per common share, to shareholders in the third quarter 2022. On November 1, 2022, the BWXT Board of Directors declared a quarterly cash dividend of $0.22 per common share payable on December 13, 2022, to shareholders of record on November 21, 2022.
2022 Guidance
(In millions, except per share amounts)As of August 8, 2022As of November 7, 2022
Year EndedYear EndedYear Ended
December 31, 2021December 31, 2022December 31, 2022
Revenues$2,124up 6.5% - 8.0%up 6.5% - 7.0%
Adjusted EBITDA(1)
$418up 5.0% - 6.5%up ~5.0%
Non-GAAP(1) Earnings Per Share
$3.06$3.08 - $3.23$3.10 - $3.15
Net Cash Provided by Operating Activities$386$260 - $290$260 - $290
Capital Expenditures$311$195 - $210< $200
2022 Segment Outlook
(In millions)As of August 8, 2022As of November 7, 2022
Revenue
Adjusted EBITDA(1)
Revenue
Adjusted EBITDA(1)
Government Operationsup 6.0% - 7.5%$400 - $405up ~6.0%~$395
Commercial Operationsup 7.5% - 8.5%$48 - $50up ~8.5%~$50
Additional information can be found in the 2022 third quarter earnings call presentation on the BWXT investor relations website at www.bwxt.com/investors. The Company does not provide GAAP guidance because it is unable to reliably forecast most of the items that are excluded from GAAP to calculate non-GAAP results. These items could cause GAAP results to differ materially from non-GAAP results.
Conference Call to Discuss Third Quarter 2022 Results
Date: Monday, November 7, 2022, at 5:00 p.m. EST
Live Webcast: Investor Relations section of website at www.bwxt.com
Full Earnings Release Available on BWXT Website
A full version of this earnings release is available on our Investor Relations website at http://investors.bwxt.com/3Q2022-release
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.

BWXT may use its website (www.bwxt.com) as a channel of distribution of material Company information. Financial and other important information regarding BWXT is routinely accessible through and posted on our website. In addition, you may elect to automatically receive e-mail alerts and other information about BWXT by enrolling through the “Email Alerts” section of our website at http://investors.bwxt.com.
Non-GAAP Measures
BWXT uses and makes reference to adjusted EBITDA, free cash flow and free cash flow conversion, which are not recognized measures under GAAP. BWXT is providing these non-GAAP measures to supplement the results provided in accordance with GAAP and it should not be considered superior to, or as a substitute for, the comparable GAAP measures. BWXT believes the non-GAAP measures provide meaningful insight and transparency into the Company’s operational performance and provides these measures to investors to help facilitate comparisons of operating results with prior periods and to assist them in understanding BWXT's ongoing operations. Definitions for the non-GAAP measures are provided below and reconciliations are detailed in Exhibit 1, except that reconciliations of forward-looking GAAP measures are not provided because the company is unable to reliably forecast most of the items that are excluded from GAAP to calculate non-GAAP results. Other companies may define these measures differently or may utilize different non-GAAP measures, thus impacting comparability.
Adjusted Earnings Before Interest, Taxes, Depreciation and Amortization (EBITDA) is calculated using non-GAAP net income, plus provision for income taxes, less other – net, less interest income, plus interest expense, plus depreciation and amortization.
Free Cash Flow (FCF) is calculated using net income to derive net cash provided by (used in) operating activities less purchases of property, plant and equipment.
Free Cash Flow conversion is free cash flow divided by net income.
Forward-Looking Statements
BWXT cautions that this release contains forward-looking statements, including, without limitation, statements relating to backlog, to the extent they may be viewed as an indicator of future revenues; our plans and expectations for each of our reportable segments, including the expectations, timing and revenue of our strategic initiatives, such as medical radioisotopes, SMR components and recent acquisitions; disruptions to our supply chain and/or operations, changes in government regulations and other factors, including any such impacts of, or actions in response to the COVID-19 health crisis; and our expectations and guidance for 2022 and beyond. These forward-looking statements are based on management’s current expectations and involve a number of risks and uncertainties, including, among other things, our ability to execute contracts in backlog; the lack of, or adverse changes in, federal appropriations to government programs in which we participate; the demand for and competitiveness of nuclear products and services; capital priorities of power generating utilities and other customers; the timing of technology development, regulatory approval and automation of production; the receipt and/or timing of government approvals; the impact of COVID-19 on our business and our employees, contractors, suppliers, customers and other partners and their business activities; the potential recurrence of subsequent waves or strains of COVID-19 or similar diseases; labor market challenges, including employee retention and recruitment; adverse changes in the industries in which we operate; and delays, changes or termination of contracts in backlog. If one or more of these risks or other risks materialize, actual results may vary materially from those expressed. For a more complete discussion of these and other risk factors, see BWXT’s filings with the Securities and Exchange Commission, including our annual report on Form 10-K for the year ended December 31, 2021 and subsequent Form 10-Q filings. BWXT cautions not to place undue reliance on these forward-looking statements, which speak only as of the date of this release, and undertakes no obligation to update or revise any forward-looking statement, except to the extent required by applicable law.
(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.

About BWXT
At BWX Technologies, Inc. (NYSE: BWXT), we are People Strong, Innovation Driven. Headquartered in Lynchburg, Va. BWXT is a Fortune 1000 and Defense News Top 100 manufacturing and engineering innovator that provides safe and effective nuclear solutions for global security, clean energy, environmental remediation, nuclear medicine and space exploration. With approximately 6,700 employees, BWXT has 14 major operating sites in the U.S., Canada and the U.K. In addition, BWXT joint ventures provide management and operations at more than a dozen U.S. Department of Energy and NASA facilities. Follow us on Twitter at @BWXT and learn more at www.bwxt.com

Investor Contact:Media Contact:
Mark KratzJud Simmons
Vice President, Investor RelationsDirector, Media and Public Relations
980-365-4300Investors@bwxt.com434-522-6462hjsimmons@bwxt.com

(1) A reconciliation of non-GAAP results are detailed in Exhibit 1. Additional information can be found in the materials on the BWXT investor relations website at www.bwxt.com/investors.

EXHIBIT 1
BWX TECHNOLOGIES, INC.
RECONCILIATION OF NON-GAAP OPERATING INCOME AND EARNINGS PER SHARE(1)(2)(3)
(In millions, except per share amounts)
Three Months Ended September 30, 2022
 GAAPRestructuring CostsAcquisition Related CostsNon-GAAP
   
Operating Income$79.9 $1.2 $0.5 $81.5 
Other Income (Expense)2.1 — — 2.1 
Provision for Income Taxes(20.2)(0.2)(0.1)(20.5)
Net Income61.8 1.0 0.4 63.2 
Net Income Attributable to Noncontrolling Interest
(0.2)— — (0.2)
Net Income Attributable to BWXT
$61.6 $1.0 $0.4 $63.0 
 
Diluted Shares Outstanding91.7 91.7 
Diluted Earnings per Common Share
$0.67 $0.01 $0.00 $0.69 
Effective Tax Rate24.6%24.5%
Government Operations Operating Income$77.7 $— $0.5 $78.2 
Commercial Operations Operating Income$6.8 $— $— $6.8 
Unallocated Corporate Operating Income$(4.7)$1.2 $— $(3.5)
Three Months Ended September 30, 2021
 GAAPRestructuring CostsCost associated with early bond redemptionNon-GAAP
   
Operating Income$87.5 $0.8 $— $88.2 
Other Income (Expense)(9.7)— 15.0 5.3 
Provision for Income Taxes(17.6)(0.2)(3.5)(21.3)
Net Income60.2 0.6 11.5 72.2 
Net Income Attributable to Noncontrolling Interest
(0.2)— — (0.2)
Net Income Attributable to BWXT
$59.9 $0.6 $11.5 $72.0 
 
Diluted Shares Outstanding94.5 94.5 
Diluted Earnings per Common Share
$0.63 $0.01 $0.12 $0.76 
Effective Tax Rate22.6%22.8%
Government Operations Operating Income$87.5 $0.2 $— $87.7 
Commercial Operations Operating Income$4.9 $0.3 $— $5.2 
Unallocated Corporate Operating Income$(5.0)$0.3 $— $(4.7)




EXHIBIT 1 (continued)
RECONCILIATION OF CONSOLIDATED ADJUSTED EBITDA(1)(2)(3)
(In millions)
Three Months Ended September 30, 2022
 GAAPRestructuring CostsAcquisition Related CostsNon-GAAP
 
Net Income$61.8 $1.0 $0.4 $63.2 
Provision for Income Taxes20.2 0.2 0.1 20.5 
Other – net(11.5)— — (11.5)
Interest Income(0.3)— — (0.3)
Interest Expense9.6 — — 9.6 
Depreciation & Amortization18.6 — — 18.6 
Adjusted EBITDA$98.5 $1.2 $0.5 $100.1 
Three Months Ended September 30, 2021
 GAAPRestructuring CostsCosts associated with early bond redemptionNon-GAAP
 
Net Income$60.2 $0.6 $11.5 $72.2 
Provision for Income Taxes17.6 0.2 3.5 21.3 
Other – net(1.6)— (10.8)(12.4)
Interest Income(0.2)— — (0.2)
Interest Expense11.5 — (4.2)7.3 
Depreciation & Amortization17.5 — — 17.5 
Adjusted EBITDA$105.0 $0.8 $— $105.7 
RECONCILIATION OF REPORTING SEGMENT ADJUSTED EBITDA(1)(2)(3)
(In millions)
Three Months Ended September 30, 2022
 Operating Income (GAAP)
Non-GAAP Adjustments(4)
Depreciation & AmortizationAdjusted EBITDA
 
Government Operations$77.7 $0.5 $12.1 $90.4 
Commercial Operations$6.8 $— $4.6 $11.5 
Three Months Ended September 30, 2021
 Operating Income (GAAP)
Non-GAAP Adjustments(4)
Depreciation & AmortizationAdjusted EBITDA
 
Government Operations$87.5 $0.2 $10.9 $98.6 
Commercial Operations$4.9 $0.3 $5.0 $10.2 



EXHIBIT 1 (continued)
RECONCILIATION OF CONSOLIDATED FREE CASH FLOW(1)(2)(3)
(In millions)
Three Months Ended September 30, 2022
 
Net Cash Provided By Operating Activities$65.0 
Purchases of Property, Plant and Equipment(39.6)
Free Cash Flow$25.4 
Three Months Ended September 30, 2021
 
Net Cash Provided By Operating Activities$67.3 
Purchases of Property, Plant and Equipment(66.5)
Free Cash Flow$0.8 
(1)
Tables may not foot due to rounding.
(2)BWXT is providing non-GAAP information regarding certain of its historical results and guidance on future earnings per share to supplement the results provided in accordance with GAAP and it should not be considered superior to, or as a substitute for, the comparable GAAP measures. BWXT believes the non-GAAP measures provide meaningful insight and transparency into the Company’s operational performance and provides these measures to investors to help facilitate comparisons of operating results with prior periods and to assist them in understanding BWXT's ongoing operations.
(3)BWXT has not included a reconciliation of provided non-GAAP guidance to the comparable GAAP measures due to the difficulty of estimating any mark-to-market adjustments for pension and post-retirement benefits, which are determined at the end of the year.
(4)For Non-GAAP adjustment details, see reconciliation of non-GAAP operating income and earnings per share.


BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(Unaudited)
(In thousands, except share and per share amounts)
Revenues$523,711 $498,727 $1,608,657 $1,532,099 
Costs and Expenses:
Cost of operations399,281 361,530 1,217,108 1,130,153 
Research and development costs1,426 2,870 6,990 9,491 
Losses (gains) on asset disposals and impairments, net(251)(981)(222)(1,018)
Selling, general and administrative expenses58,160 58,458 172,974 176,037 
Total Costs and Expenses458,616 421,877 1,396,850 1,314,663 
Equity in Income of Investees14,783 10,618 34,881 26,197 
Operating Income79,878 87,468 246,688 243,633 
Other Income (Expense):
Interest income273 160 463 369 
Interest expense(9,625)(11,483)(24,983)(28,725)
Other – net11,496 1,624 35,401 33,316 
Total Other Income (Expense)2,144 (9,699)10,881 4,960 
Income before Provision for Income Taxes
82,022 77,769 257,569 248,593 
Provision for Income Taxes20,185 17,611 61,977 59,211 
Net Income$61,837 $60,158 $195,592 $189,382 
Net Income Attributable to Noncontrolling Interest(234)(244)(366)(372)
Net Income Attributable to BWX Technologies, Inc.$61,603 $59,914 $195,226 $189,010 
Earnings per Common Share:
Basic:
Net Income Attributable to BWX Technologies, Inc.$0.67 $0.64 $2.13 $1.99 
Diluted:
Net Income Attributable to BWX Technologies, Inc.$0.67 $0.63 $2.13 $1.99 
Shares used in the computation of earnings per share:
Basic91,407,599 94,277,253 91,455,350 94,978,638 
Diluted91,655,536 94,483,975 91,665,383 95,190,676 


BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
Nine Months Ended September 30,
20222021
(Unaudited) (In thousands)
CASH FLOWS FROM OPERATING ACTIVITIES:
Net Income$195,592 $189,382 
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization54,808 50,476 
Income of investees, net of dividends(10,733)(12,375)
Recognition of losses for pension and postretirement plans2,441 2,189 
Stock-based compensation expense12,047 14,861 
Premium for early redemption of senior notes— 10,752 
Recognition of debt issuance costs from former debt instruments— 4,212 
Other, net1,966 1,039 
Changes in assets and liabilities, net of effects from acquisitions:
Accounts receivable10,518 99,604 
Accounts payable(17,996)(20,787)
Retainages(24,684)(14,780)
Contracts in progress and advance billings on contracts(42,824)(71,020)
Income taxes(4,019)15,723 
Accrued and other current liabilities(8,487)1,922 
Pension liabilities, accrued postretirement benefit obligations and employee benefits(34,994)(53,430)
Other, net3,400 7,810 
NET CASH PROVIDED BY OPERATING ACTIVITIES137,035 225,578 
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchases of property, plant and equipment(134,591)(236,656)
Acquisition of business, net of cash acquired(47,328)— 
Purchases of securities(2,700)(3,560)
Sales and maturities of securities2,667 3,417 
Investments, net of return of capital, in equity method investees(11,450)— 
Other, net324 2,718 
NET CASH USED IN INVESTING ACTIVITIES(193,078)(234,081)
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings of long-term debt373,700 1,215,800 
Repayments of long-term debt(223,700)(825,800)
Premium for early redemption of senior notes— (10,752)
Payment of debt issuance costs— (4,838)
Repayment of bank overdraft— (88,694)
Repurchases of common stock(20,000)(185,778)
Dividends paid to common shareholders(60,894)(60,277)
Exercises of stock options57 2,011 
Cash paid for shares withheld to satisfy employee taxes(6,588)(5,031)
Settlements of forward contracts, net13,917 (1,167)
Other(204)(115)
NET CASH PROVIDED BY FINANCING ACTIVITIES76,288 35,359 
EFFECTS OF EXCHANGE RATE CHANGES ON CASH(3,093)155 
TOTAL INCREASE IN CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS17,152 27,011 
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS AT BEGINNING OF PERIOD39,775 48,298 
CASH AND CASH EQUIVALENTS AND RESTRICTED CASH AND CASH EQUIVALENTS AT END OF PERIOD$56,927 $75,309 
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid during the period for:
Interest$26,809 $32,209 
Income taxes (net of refunds)$67,555 $43,236 
SCHEDULE OF NON-CASH INVESTING ACTIVITY:
Accrued capital expenditures included in accounts payable$7,427 $25,106 


BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS

ASSETS
September 30,
2022		December 31,
2021
(Unaudited)
(In thousands)
Current Assets:
Cash and cash equivalents$51,400 $33,891 
Restricted cash and cash equivalents2,908 2,896 
Investments3,820 3,811 
Accounts receivable – trade, net72,404 70,663 
Accounts receivable – other34,145 16,651 
Retainages76,193 51,507 
Contracts in progress545,517 546,595 
Other current assets63,317 47,718 
Total Current Assets849,704 773,732 
Property, Plant and Equipment, Net1,083,436 1,045,640 
Investments7,769 9,558 
Goodwill289,962 285,502 
Deferred Income Taxes20,458 21,394 
Investments in Unconsolidated Affiliates107,430 85,284 
Intangible Assets192,898 185,551 
Other Assets120,401 94,719 
TOTAL$2,672,058 $2,501,380 



BWX TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
LIABILITIES AND STOCKHOLDERS' EQUITY
September 30,
2022		December 31,
2021
(Unaudited)
(In thousands, except share
and per share amounts)
Current Liabilities:
Accounts payable$146,543 $189,842 
Accrued employee benefits75,114 71,835 
Accrued liabilities – other80,749 80,998 
Advance billings on contracts98,545 111,619 
Accrued warranty expense5,846 5,321 
Total Current Liabilities406,797 459,615 
Long-Term Debt1,340,722 1,189,304 
Accumulated Postretirement Benefit Obligation21,553 24,333 
Environmental Liabilities94,414 92,642 
Pension Liability48,018 59,388 
Other Liabilities47,618 38,863 
Commitments and Contingencies
Stockholders' Equity:
Common stock, par value $0.01 per share, authorized 325,000,000 shares; issued 127,638,048 and 127,311,985 shares at September 30, 2022 and December 31, 2021, respectively1,276 1,273 
Preferred stock, par value $0.01 per share, authorized 75,000,000 shares; No shares issued— — 
Capital in excess of par value186,790 174,288 
Retained earnings1,910,197 1,775,751 
Treasury stock at cost, 36,420,960 and 35,915,747 shares at September 30, 2022 and December 31, 2021, respectively(1,353,269)(1,326,280)
Accumulated other comprehensive income (loss)(32,280)12,143 
Stockholders' Equity – BWX Technologies, Inc.712,714 637,175 
Noncontrolling interest222 60 
Total Stockholders' Equity712,936 637,235 
TOTAL$2,672,058 $2,501,380 


BWX TECHNOLOGIES, INC.
BUSINESS SEGMENT INFORMATION
Three Months Ended September 30,Nine Months Ended September 30,
2022202120222021
(Unaudited)
(In thousands)
REVENUES:
Government Operations$422,521 $417,139 $1,290,835 $1,245,911 
Commercial Operations101,794 83,382 320,266 292,622 
Eliminations(604)(1,794)(2,444)(6,434)
TOTAL$523,711 $498,727 $1,608,657 $1,532,099 
 
SEGMENT INCOME:
Government Operations$77,735 $87,542 $233,749 $238,658 
Commercial Operations6,847 4,925 23,673 16,859 
SUBTOTAL84,582 92,467 257,422 255,517 
Unallocated Corporate(4,704)(4,999)(10,734)(11,884)
TOTAL$79,878 $87,468 $246,688 $243,633 
 
DEPRECIATION AND AMORTIZATION:
Government Operations$12,137 $10,928 $35,258 $30,433 
Commercial Operations4,603 4,985 14,465 14,939 
Corporate1,852 1,571 5,085 5,104 
TOTAL$18,592 $17,484 $54,808 $50,476 
 
CAPITAL EXPENDITURES:
Government Operations$19,126 $34,155 $66,195 $110,173 
Commercial Operations17,815 30,546 63,559 118,441 
Corporate2,704 1,785 4,837 8,042 
TOTAL$39,645 $66,486 $134,591 $236,656 
BACKLOG:
Government Operations$3,686,469 $3,813,289 $3,686,469 $3,813,289 
Commercial Operations632,416 687,806 632,416 687,806 
TOTAL$4,318,885 $4,501,095 $4,318,885 $4,501,095 
BOOKINGS:
Government Operations$119,086 $53,989 $398,232 $1,373,286 
Commercial Operations2,790 96,780 308,750 254,081 
TOTAL$121,876 $150,769 $706,982 $1,627,367